Literature DB >> 19055663

Postdischarge pain, functional limitations and impact on caregivers of children with sickle cell disease treated for painful events.

Amanda M Brandow1, David C Brousseau, Julie A Panepinto.   

Abstract

This study aimed to describe the outcomes of children with sickle cell disease (SCD) after discharge from medical care for vaso-occlusive painful events and to test the hypothesis that older age, longer length of hospital stay, and a history of frequent vaso-occlusive painful events will be associated with poor outcomes. Children aged 2-18 years with SCD treated in the emergency department or inpatient unit for a painful event were contacted after discharge to assess: days of pain, days of functional limitations for the child, and days of work/school absenteeism for the caregiver. Descriptive statistics were applied and multivariate logistic regression examined the association between the predictors and outcomes. Fifty-eight children were enrolled (mean age 10.8 +/- 4.8 years, 53.5% female). Postdischarge, 46.5% of children reported three or more days of pain, 54.3% had two or more days of functional limitations, and 24.3% of caregivers missed two or more days of work/school. Children with three or more prior painful events had increased odds of a poor outcome postdischarge (OR 1.79; 95% CI = 1.026, 3.096). In conclusion, acute vaso-occlusive painful events impact the lives of children with SCD and their caregivers, even after discharge to home.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19055663      PMCID: PMC3118502          DOI: 10.1111/j.1365-2141.2008.07512.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  26 in total

Review 1.  Chronic health conditions and student performance at school.

Authors:  Howard Taras; William Potts-Datema
Journal:  J Sch Health       Date:  2005-09       Impact factor: 2.118

2.  Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease.

Authors:  Debra L Weiner; Patricia L Hibberd; Peter Betit; Andrew B Cooper; Christine A Botelho; Carlo Brugnara
Journal:  JAMA       Date:  2003-03-05       Impact factor: 56.272

3.  Cognitive deficits in children with sickle cell disease.

Authors:  R Grant Steen; Charlotte Fineberg-Buchner; Gisele Hankins; Larry Weiss; Aurelio Prifitera; Raymond K Mulhern
Journal:  J Child Neurol       Date:  2005-02       Impact factor: 1.987

4.  Child health status and parental employment.

Authors:  K A Kuhlthau; J M Perrin
Journal:  Arch Pediatr Adolesc Med       Date:  2001-12

5.  Short-term outcomes of pediatric emergency department febrile illnesses.

Authors:  Rakesh D Mistry; Molly W Stevens; Marc H Gorelick
Journal:  Pediatr Emerg Care       Date:  2007-09       Impact factor: 1.454

6.  Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial.

Authors:  A Ferster; C Vermylen; G Cornu; M Buyse; F Corazza; C Devalck; P Fondu; M Toppet; E Sariban
Journal:  Blood       Date:  1996-09-15       Impact factor: 22.113

7.  Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research.

Authors:  Julie A Panepinto; Mark C Walters; Jeanette Carreras; Judith Marsh; Christopher N Bredeson; Robert Peter Gale; Gregory A Hale; John Horan; Jill M Hows; John P Klein; Ricardo Pasquini; Irene Roberts; Keith Sullivan; Mary Eapen; Alina Ferster
Journal:  Br J Haematol       Date:  2007-04-24       Impact factor: 6.998

8.  Daily assessment of pain in adults with sickle cell disease.

Authors:  Wally R Smith; Lynne T Penberthy; Viktor E Bovbjerg; Donna K McClish; John D Roberts; Bassam Dahman; Imoigele P Aisiku; James L Levenson; Susan D Roseff
Journal:  Ann Intern Med       Date:  2008-01-15       Impact factor: 25.391

9.  Caregiver report of pain in infants and toddlers with sickle cell disease: reliability and validity of a daily diary.

Authors:  Beth Ely; Carlton Dampier; Miriam Gilday; Patricia O'Neal; Darcy Brodecki
Journal:  J Pain       Date:  2002-02       Impact factor: 5.820

10.  Employment barriers among welfare recipients and applicants with chronically ill children.

Authors:  Lauren A Smith; Diana Romero; Pamela R Wood; Nina S Wampler; Wendy Chavkin; Paul H Wise
Journal:  Am J Public Health       Date:  2002-09       Impact factor: 9.308

View more
  16 in total

1.  Psychosocial burden of sickle cell disease on parents with an affected child in Cameroon.

Authors:  Ambroise Wonkam; Caryl Zameyo Mba; Dora Mbanya; Jeanne Ngogang; Raj Ramesar; Fru F Angwafo
Journal:  J Genet Couns       Date:  2013-07-24       Impact factor: 2.537

2.  Impact of hereditary pancreatitis on patients and their families.

Authors:  Celeste A Shelton; Robin E Grubs; Chandraprakash Umapathy; Dhiraj Yadav; David C Whitcomb
Journal:  J Genet Couns       Date:  2020-02-05       Impact factor: 2.537

3.  The impact of a multidisciplinary pain management model on sickle cell disease pain hospitalizations.

Authors:  Amanda M Brandow; Steven J Weisman; Julie A Panepinto
Journal:  Pediatr Blood Cancer       Date:  2010-12-15       Impact factor: 3.167

4.  Health-related quality of life in children with sickle cell disease: a report from the Comprehensive Sickle Cell Centers Clinical Trial Consortium.

Authors:  Carlton Dampier; Susan Lieff; Petra LeBeau; Seungshin Rhee; Marsha McMurray; Zora Rogers; Kim Smith-Whitley; Winfred Wang
Journal:  Pediatr Blood Cancer       Date:  2010-09       Impact factor: 3.167

5.  Hydroxyurea in children with sickle cell disease: practice patterns and barriers to utilization.

Authors:  Amanda M Brandow; Danielle L Jirovec; Julie A Panepinto
Journal:  Am J Hematol       Date:  2010-08       Impact factor: 10.047

6.  Hydroxyurea use in sickle cell disease: the battle with low prescription rates, poor patient compliance and fears of toxicities.

Authors:  Amanda M Brandow; Julie A Panepinto
Journal:  Expert Rev Hematol       Date:  2010-06       Impact factor: 2.929

7.  IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies.

Authors:  Carlton D Dampier; Wally R Smith; Carrie G Wager; Hae-Young Kim; Margaret C Bell; Scott T Miller; Debra L Weiner; Caterina P Minniti; Lakshmanan Krishnamurti; Kenneth I Ataga; James R Eckman; Lewis L Hsu; Donna McClish; Sonja M McKinlay; Robert Molokie; Ifeyinwa Osunkwo; Kim Smith-Whitley; Marilyn J Telen
Journal:  Clin Trials       Date:  2013-04       Impact factor: 2.486

8.  A pilot study of parent education intervention improves early childhood development among toddlers with sickle cell disease.

Authors:  Melanie E Fields; Catherine Hoyt-Drazen; Regina Abel; Mark J Rodeghier; Janet M Yarboi; Bruce E Compas; Allison A King
Journal:  Pediatr Blood Cancer       Date:  2016-08-11       Impact factor: 3.167

9.  Impact of hydroxyurea on clinical events in the BABY HUG trial.

Authors:  Courtney D Thornburg; Beatrice A Files; Zhaoyu Luo; Scott T Miller; Ram Kalpatthi; Rathi Iyer; Phillip Seaman; Jeffrey Lebensburger; Ofelia Alvarez; Bruce Thompson; Russell E Ware; Winfred C Wang
Journal:  Blood       Date:  2012-08-22       Impact factor: 22.113

10.  Breathing Exercises for Inpatients with Sickle Cell Disease.

Authors:  Nadine Matthie; Cheryl A Brewer; Vera L Moura; Coretta M Jenerette
Journal:  Medsurg Nurs       Date:  2015 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.